LOXL2 and tongue neoplasm: IHC staining of the tongue tissues indicate that treatment of mice with LOXL2 inhibitor PXS-S1C decreased levels of PCNA (Fig. 4a) and LOXL2 (Fig. 4b) in LY2 tongue tumors.